These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 3549167)

  • 1. Cyclosporine increases rat heart weight in heterotopic transplants.
    Sadeghi AM; Spotnitz HM; Thomas WA; Marboe CC; Smith CR; Rose EA; Reemtsma K
    Curr Surg; 1987; 44(1):51-2. PubMed ID: 3549167
    [No Abstract]   [Full Text] [Related]  

  • 2. The synergistic effect of cyclosporine and mizoribine on heterotopic heart and partial-lung transplantation in rats.
    Suzuki S; Hijioka T; Sakakibara I; Amemiya H
    Transplantation; 1987 May; 43(5):743-4. PubMed ID: 3107177
    [No Abstract]   [Full Text] [Related]  

  • 3. Modification of function and migration patterns of thymocyte populations by cyclosporine after organ transplantation in rats.
    Kupiec-Weglinski JW; Lear PA; Heidecke CD; Tilney NL
    Transplantation; 1984 Jun; 37(6):631-3. PubMed ID: 6375020
    [No Abstract]   [Full Text] [Related]  

  • 4. Cyclosporine related hypertension and nephrotoxicity in rat heart transplantation.
    Kanehira A; Shida T; Nakamura H; Wakita N; Ito H; Nakamura K
    Dev Toxicol Environ Sci; 1986; 14():141-7. PubMed ID: 3549246
    [No Abstract]   [Full Text] [Related]  

  • 5. Proceedings: passive enhancement of heterotopic rat heart transplants.
    Bell PR; Tilney NL
    Br J Surg; 1973 Nov; 60(11):907-8. PubMed ID: 4584780
    [No Abstract]   [Full Text] [Related]  

  • 6. Cyclosporine administration decreases liver vitamin A stores in normal and vitamin A-deficient rats.
    Azaïs V; Rachman F; Gros S; Pascal G; Amédée-Manesme O
    Drug Nutr Interact; 1987; 5(2):81-8. PubMed ID: 3608831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histologic pattern of early heart allograft rejection under cyclosporine treatment.
    Ueda K; Baumgartner WA; Beschorner WE; Borkon MA; Soule LM; Reitz BR; Herskowitz A
    J Heart Transplant; 1985 May; 4(3):296-301. PubMed ID: 3916500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of cyclosporine on cardiac xenograft survival.
    Sugimoto K; Shelby J; Corry RJ
    Transplantation; 1985 Feb; 39(2):218-9. PubMed ID: 3881859
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of cyclosporine and some derivatives on chronic rejection.
    Lu X; Dawson J; Borel JF
    Transplant Proc; 1996 Dec; 28(6):3152-3. PubMed ID: 8962221
    [No Abstract]   [Full Text] [Related]  

  • 10. Preoperative total-lymphoid irradiation, splenectomy, and postoperative cyclosporine in the rat cardiac heterograft model.
    Downing TP; Sadeghi AM; Bieber CP; Aziz S; Reitz BA; Shumway NE
    Transplantation; 1985 Jan; 39(1):81-3. PubMed ID: 3880968
    [No Abstract]   [Full Text] [Related]  

  • 11. Histologic changes in atrophic spleens of mice treated with cyclosporine A.
    Daar AS; Pingle S; Naiem M; Masri MA
    Transplant Proc; 1987 Oct; 19(5):4329-30. PubMed ID: 3672622
    [No Abstract]   [Full Text] [Related]  

  • 12. FTY720, a novel immunosuppressant possessing unique mechanisms. II. Long-term graft survival induction in rat heterotopic cardiac allografts and synergistic effect in combination with cyclosporine A.
    Hoshino Y; Suzuki C; Ohtsuki M; Masubuchi Y; Amano Y; Chiba K
    Transplant Proc; 1996 Apr; 28(2):1060-1. PubMed ID: 8623226
    [No Abstract]   [Full Text] [Related]  

  • 13. KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts.
    Shimizu H; Takahashi M; Kaneko T; Murakami T; Hakamata Y; Kudou S; Kishi T; Fukuchi K; Iwanami S; Kuriyama K; Yasue T; Enosawa S; Matsumoto K; Takeyoshi I; Morishita Y; Kobayashi E
    Circulation; 2005 Jan; 111(2):222-9. PubMed ID: 15642767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transplantation-induced atrophy of normal and hypertrophic rat hearts: effect on cardiac myocytes and capillaries.
    Rakusan K; Heron MI; Kolar F; Korecky B
    J Mol Cell Cardiol; 1997 Mar; 29(3):1045-54. PubMed ID: 9152865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Auxiliary liver-heart transplantation in the rat: a new microsurgical model inducing tolerance.
    Jiang M; Han D
    Transplant Proc; 2004 Jun; 36(5):1607-9. PubMed ID: 15251395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclosporine dosage can be reduced when used in combination with an anti-intercellular adhesion molecule-1 monoclonal antibody in rats undergoing heterotopic heart transplantation.
    Harrison PC; Mainolfi E; Madwed JB
    J Heart Lung Transplant; 1998 Feb; 17(2):150-7. PubMed ID: 9513853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific unresponsiveness to allografts induced by cyclosporine is not antibody dependent.
    Hall BM; Jelbart ME; Dorsch SE
    Transplant Proc; 1985 Apr; 17(2):1650-2. PubMed ID: 3885499
    [No Abstract]   [Full Text] [Related]  

  • 18. Development of a new carrier for cyclosporine A with selectivity for lymphatics.
    Takada K; Furuya Y; Nakata T; Yoshikawa H; Muranishi S; Yasumura T; Oka T
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1711-2. PubMed ID: 3274409
    [No Abstract]   [Full Text] [Related]  

  • 19. Analysis of allogeneic and syngeneic rat heart transplants using 23Na magnetic resonance spectroscopy.
    Waldrop SM; Alexander DZ; Lowry R; Winn KJ; Pearson TC; Constantinidis I
    Biochem Biophys Res Commun; 1996 Jun; 223(2):379-83. PubMed ID: 8670290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclosporine therapy of rat heart allograft recipients and release of interleukins (IL 1, IL 2, IL 3): a role for IL 3 in graft tolerance?
    Abbud-Filho M; Kupiec-Weglinski JW; Araujo JL; Heidecke CD; Tilney NL; Strom TB
    J Immunol; 1984 Nov; 133(5):2582-6. PubMed ID: 6237152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.